Clinical trials start for new COVID-19 vaccine candidate from Valneva By: MarketWatch December 16, 2020 at 06:04 AM EST The U.K. has spent almost £12 billion ($16 billion) so far to secure, make and administer hundreds of millions of coronavirus shots. Read More >> Related Stocks: Biontech Se ADR Pfizer Valneva Se